Physician profile
Joycelyn A Adom
NPI 1295301182
$2,984.68
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.22 · 2022: $2,257 · 2023: $660 · 2024: $47.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $636.77 | 2022-2023 | Fasenra, Breztri |
| Glaxosmithkline, LLC. | $508.60 | 2022-2023 | Trelegy Ellipta, Nucala |
| Paratek Pharmaceuticals, INC. | $263.16 | 2022-2023 | Nuzyra |
| Amgen INC. | $189.20 | 2022-2023 | Tezspire |
| United Therapeutics Corporation | $177.47 | 2022-2023 | Tyvaso |
| Takeda Pharmaceuticals U.S.A., INC. | $154.58 | 2022-2023 | Glassia |
| Novartis Pharmaceuticals Corporation | $145.33 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.83 | 2022 | |
| Mallinckrodt Hospital Products INC. | $105.96 | 2022-2023 | Acthar |
| Regeneron Healthcare Solutions, INC. | $87.83 | 2022-2023 | Dupixent |
| Inogen, INC. | $84.83 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Pfizer INC. | $79.63 | 2022-2024 | |
| Grifols USA, LLC | $70.95 | 2022-2023 | Prolastin-C Liquid |
| Teva Pharmaceuticals USA, INC. | $69.63 | 2022 | |
| Electromed, INC. | $52.63 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $51.15 | 2022-2023 | Ruconest |
| Mylan Specialty L.P. | $37.43 | 2022 | |
| Insmed, INC. | $34.16 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.13 | 2022 | |
| Astellas Pharma US INC | $24.72 | 2022 | |
| Ani Pharmaceuticals, INC. | $22.79 | 2023 | Purified Cortrophin Gel |
| Baxter Healthcare | $17.20 | 2022 | |
| Phadia US INC. | $13.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joycelyn Adom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.